174 related articles for article (PubMed ID: 38295754)
1. Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies.
Najafiyan B; Bokaii Hosseini Z; Esmaelian S; Firuzpour F; Rahimipour Anaraki S; Kalantari L; Hheidari A; Mesgari H; Nabi-Afjadi M
Biomed Pharmacother; 2024 Mar; 172():116207. PubMed ID: 38295754
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells.
Luo H; Wang L; Schulte BA; Yang A; Tang S; Wang GY
Int J Oncol; 2013 Dec; 43(6):1999-2006. PubMed ID: 24141489
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells.
Zhang W; Wang X; Chen T
Cell Signal; 2012 May; 24(5):1037-46. PubMed ID: 22245142
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of resveratrol and its silver nanoparticle conjugate in addressing sepsis-induced lung injury.
Üstündağ H; Kara A; Doğanay S; Kurt N; Erbaş E; Kalindemirtaş FD; Kariper İA
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38546748
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits viability and induces apoptosis in the small‑cell lung cancer H446 cell line via the PI3K/Akt/c‑Myc pathway.
Li W; Li C; Ma L; Jin F
Oncol Rep; 2020 Nov; 44(5):1821-1830. PubMed ID: 32901891
[TBL] [Abstract][Full Text] [Related]
6. Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation.
Rahman M; Almalki WH; Afzal O; Alfawaz Altamimi AS; Kazmi I; Al-Abbasi FA; Choudhry H; Alenezi SK; Barkat MA; Beg S; Kumar V; Alhalmi A
Int J Nanomedicine; 2020; 15():9283-9299. PubMed ID: 33262588
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
8. Targeting mTOR: evaluating the therapeutic potential of resveratrol for cancer treatment.
Wu Y; Liu F
Anticancer Agents Med Chem; 2013 Sep; 13(7):1032-8. PubMed ID: 23272906
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the cancer inhibitory effect of the bioactive food component resveratrol by nanoparticle based delivery.
Bano S; Ahmed F; Khan F; Chaudhary SC; Samim M
Food Funct; 2020 Apr; 11(4):3213-3226. PubMed ID: 32215382
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems.
Gencer A; Duraloglu C; Ozbay S; Ciftci TT; Yabanoglu-Ciftci S; Arica B
Curr Drug Deliv; 2021; 18(2):103-120. PubMed ID: 32748745
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol (RV): A pharmacological review and call for further research.
Zhang LX; Li CX; Kakar MU; Khan MS; Wu PF; Amir RM; Dai DF; Naveed M; Li QY; Saeed M; Shen JQ; Rajput SA; Li JH
Biomed Pharmacother; 2021 Nov; 143():112164. PubMed ID: 34649335
[TBL] [Abstract][Full Text] [Related]
12. The Pharmacological Potential of Resveratrol in Reducing Soft Tissue Damage in Osteoarthritis Patients.
Singh K; Gupta JK; Kumar S
Curr Rheumatol Rev; 2024; 20(1):27-38. PubMed ID: 37694798
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin Complexation for Enhanced Stability and Non-invasive Pulmonary Delivery of Resveratrol-Applications in Non-small Cell Lung Cancer Treatment.
Wang X; Parvathaneni V; Shukla SK; Kanabar DD; Muth A; Gupta V
AAPS PharmSciTech; 2020 Jul; 21(5):183. PubMed ID: 32632576
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
Nie P; Hu W; Zhang T; Yang Y; Hou B; Zou Z
Cell Physiol Biochem; 2015; 35(6):2255-71. PubMed ID: 25895606
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved.
Bian P; Hu W; Liu C; Li L
Arch Biochem Biophys; 2020 Aug; 689():108461. PubMed ID: 32531316
[TBL] [Abstract][Full Text] [Related]
16. Extract of Murraya koenigii selectively causes genomic instability by altering redox-status via targeting PI3K/AKT/Nrf2/caspase-3 signaling pathway in human non-small cell lung cancer.
Mondal P; Natesh J; Penta D; Meeran SM
Phytomedicine; 2022 Sep; 104():154272. PubMed ID: 35728387
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage.
Luo H; Yang A; Schulte BA; Wargovich MJ; Wang GY
PLoS One; 2013; 8(3):e60065. PubMed ID: 23533664
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Lamprecht A; Arica B
Int J Pharm; 2024 Jan; 650():123703. PubMed ID: 38092263
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease.
Gowd V; Kanika ; Jori C; Chaudhary AA; Rudayni HA; Rashid S; Khan R
J Nutr Biochem; 2022 Nov; 109():109101. PubMed ID: 35777588
[TBL] [Abstract][Full Text] [Related]
20. Recent Overview of Resveratrol's Beneficial Effects and Its Nano-Delivery Systems.
Bohara RA; Tabassum N; Singh MP; Gigli G; Ragusa A; Leporatti S
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
